The Continuous Peripheral Nerve Block Catheter Market is slated to be valued at US$ 585.6 million in 2023. The continuous peripheral nerve block catheter market is expected to reach US$ 1,058.6 million by 2033. Continuous peripheral nerve block catheter market revenue will continue to expand at a CAGR of 6.1%.
Attributes | Key Insights |
---|---|
Continuous Peripheral Nerve Block Catheter Market Estimated Size in 2023 | US$ 585.6 million |
Projected Market Value in 2033 | US$ 1,058.6 million |
Value-based CAGR from 2023 to 2033 | 6.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A 5.6% CAGR was experienced between 2018 and 2022 in the continuous peripheral nerve block catheter market. Global demand for continuous peripheral nerve block catheters is predicted to increase at a CAGR of 6.1% from 2023 to 2033.
The continuous peripheral nerve block catheters are an effective alternative to regional anesthesia procedures used in major orthopedic surgeries. Cost-effectiveness offered by continuous peripheral nerve block catheter and reduced hospital stay is further fueling revenue growth of the continuous peripheral nerve block catheter market.
Macroeconomic factors such as high unmet patient needs, government reimbursement plans, and strengthening of distribution network by key players in the continuous peripheral nerve block catheter market are other factors that are going to drive the market in the future.
Historical CAGR from 2018 to 2022 | 5.6% |
---|---|
Forecast CAGR from 2023 to 2033 | 6.1% |
Future Market Insights has compared two other markets, namely the balloon catheter market and the central venous catheter market below. The growing geriatric population is translating into staggering orthopedic procedure volume, which in turn is fueling the demand for postoperative pain management solutions, driving the growth of the continuous peripheral nerve block catheter market
Continuous Peripheral Nerve Block Catheter Market:
CAGR from 2023 to 2033 | 6.1% |
---|---|
Market Value in 2033 | US$ 1,058.6 million |
Key Trends |
|
Opportunities |
|
Balloon Catheter Market:
CAGR from 2023 to 2033 | 4.3% |
---|---|
Market Value in 2033 | US$ 6.4 million |
Key Trends |
|
Opportunities |
|
Central Venous Catheter Market:
CAGR from 2023 to 2033 | 5.1% |
---|---|
Market Value in 2033 | US$ 5.3 million |
Key Trends |
|
Opportunities |
|
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and the United Kingdom. Through 2033, these two countries will dominate the market, with a size of US$ 245.6 million and US$ 235.4 million respectively.
Germany | US$ 228.5 million |
---|---|
India | US$ 156.7 million |
United States | US$ 245.6 million |
China | US$ 218.4 million |
United Kingdom | US$ 235.4 million |
Germany | 5.7% |
---|---|
India | 5.4% |
United States | 5.9% |
China | 5.5% |
United Kingdom | 5.8% |
The continuous peripheral nerve block catheter market in the United States will thrive at a CAGR of 5.9% through 2033. The United States has a sophisticated healthcare system that provides excellent medical treatment.
The most recent medical technologies, such as continuous peripheral nerve block catheters, are available in contemporary hospitals and healthcare institutions to satisfy patient needs. Home healthcare services are gaining traction in the United States as a way to relieve hospital overcrowding and deliver more patient-centered care.
The United States is the largest market for continuous peripheral nerve block catheters. The growth of the market in the region is attributed to the high number of surgical procedures and a growing demand for advanced pain management solutions.
According to projections, the continuous peripheral nerve block catheters market in Germany will expand by 5.7% CAGR from 2023 to 2033. At the end of the forecast period, the market is expected to be worth US$ 228.5 million.
Germany is one of the leading markets for continuous peripheral nerve block catheters in Europe. The country is known for its strong healthcare infrastructure and advanced medical technologies.
Continuous innovation and product development by German manufacturers contribute to market growth. The market for these catheters has been influenced by evolving healthcare policies and the emphasis on improving patient outcomes.
From 2023 to 2033, the continuous peripheral nerve block catheters market in the United Kingdom is anticipated to rise at a 5.8% CAGR. By the end of the said forecast period, a valuation of US$ 235.4 million is expected.
The continuous peripheral nerve block catheter market benefits from the increasing number of surgeries performed in the region, including orthopedic procedures, joint replacements, trauma surgeries, and more.
The emphasis on effective pain management and the desire to reduce opioid dependency has driven healthcare providers to explore alternative methods like continuous peripheral nerve block catheters.
China’s continuous peripheral nerve block catheter market will rise at a 5.5% CAGR through 2033. By the end of this forecast period, China's chromium picolinate market is likely to total US$ 218.4 million.
China is rapidly urbanizing, and the proportion of urban residents is rising. With the growth of contemporary healthcare infrastructure and facilities, there is an increased need for cutting-edge medical tools like continuous peripheral nerve block catheters. The market is characterized by a growing number of healthcare facilities and the adoption of innovative medical devices.
The continuous peripheral nerve block catheter market in India is expected to reach a value of US$ 156.7 million. The market in India is poised to expand at a CAGR of 5.4% through 2033.
The continuous peripheral nerve block catheter market in India is experiencing rapid growth owing to the increasing number of surgeries, including orthopedic and trauma procedures. There is a growing awareness of the benefits of continuous peripheral nerve block catheters among healthcare providers, boosting the market demand in the region.
According to market forecasts, the non-stimulating catheter is predicted to dominate until 2033, growing at a CAGR of 6.0%. The hospitals are expected to expand at a CAGR of 5.9% during the forecast period.
Category | CAGR from 2023 to 2033 |
---|---|
Non-stimulating catheters | 6.0% |
Hospitals | 5.9% |
Based on product type, the continuous peripheral nerve block catheter market is segmented into stimulating catheter systems, non-stimulating catheter systems, and over-the-needle catheter systems.
In terms of value, the non-stimulating catheter system segment is expected to account for the maximum share of the global continuous peripheral nerve block catheter market over the forecast period. The nonstimulating catheter is expected to remain dominant through 2033. The market is expected to expand at 6.0% between 2023 and 2033.
By end-user, the hospital segment is expected to dominate all other applications in the near future. A growth rate of 5.9% is projected from 2023 to 2033.
Hospitals offer a variety of medical specializations, such as intensive care units (ICUs), surgery, pain management, and other indications. Continuous peripheral nerve block catheters are used in many medical departments and specializations; hospitals serve as the primary destination for continuous peripheral nerve block catheter demand. The infrastructure, supplies, and personnel needed to operate and maintain continuous peripheral nerve block catheters efficiently are often available in hospitals.
The presence of a significant number of prominent players in various regions contributes to the market growth hugely. Ongoing Research and Development (R&D) operations to develop improved technologies, as well as new product innovation provide more potential for the continuous peripheral nerve block catheter market share.
Key developments in the market include advancements in nerve localization technologies, and the launch of the Solo-Dex catheter, which reduces the procedural times to between two to three minutes. The market is subject to changes in relevance to government reimbursement plans, product adoption rates, and disease epidemiology dynamics.
Attributes | Details |
---|---|
Estimated Market Size in 2023 | US$ 585.6 million |
Projected Market Valuation in 2033 | US$ 1,058.6 million |
Value-based CAGR 2023 to 2033 | 6.1% |
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | Value in US$ million |
Key Regions Covered |
|
Key Market Segments Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
As of 2023, the market for continuous peripheral nerve block catheters is expected to be valued at US$ 585.6 million, as per FMI
By 2033, the market value of continuous peripheral nerve block catheters is expected to reach US$ 1058.6 million
From 2023 to 2033, continuous peripheral nerve block catheter sales are expected to flourish at a CAGR of 6.1%
The hospital segment is expected to account for a CAGR of 5.9% during the forecast period.
The United States is likely to be the top-performing market, accounting for US$ 245.6 million in 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Stimulating Catheter 5.3.1.1. Open Tip Catheter Stimulating Catheter 5.3.1.2. Closed Tip Catheter Stimulating Catheter 5.3.2. Non-Stimulating Catheter 5.3.2.1. Open Tip Catheter Non-Stimulating Catheter 5.3.2.2. Closed Tip Catheter Non-Stimulating Catheter 5.3.3. Over-The-Needle Catheter 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Insertion Technique 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Insertion Technique, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Insertion Technique, 2023 to 2033 6.3.1. Nerve Stimulation Based Insertion 6.3.2. Ultrasound Based Insertion 6.4. Y-o-Y Growth Trend Analysis By Insertion Technique, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Insertion Technique, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033 7.3.1. Trauma Cases 7.3.2. Upper Extremity Surgeries 7.3.3. Lower extremity Surgeries 7.3.4. Pain Management 7.3.5. Other Indications 7.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Hospitals 8.3.2. Ambulatory Surgical Centers 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Product Type 10.2.3. By Insertion Technique 10.2.4. By Indication 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Insertion Technique 10.3.4. By Indication 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product Type 11.2.3. By Insertion Technique 11.2.4. By Indication 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Insertion Technique 11.3.4. By Indication 11.3.5. By End User 11.4. Key Takeaways 12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Product Type 12.2.3. By Insertion Technique 12.2.4. By Indication 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Insertion Technique 12.3.4. By Indication 12.3.5. By End User 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Product Type 13.2.3. By Insertion Technique 13.2.4. By Indication 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Insertion Technique 13.3.4. By Indication 13.3.5. By End User 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Product Type 14.2.3. By Insertion Technique 14.2.4. By Indication 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Insertion Technique 14.3.4. By Indication 14.3.5. By End User 14.4. Key Takeaways 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Product Type 15.2.3. By Insertion Technique 15.2.4. By Indication 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Insertion Technique 15.3.4. By Indication 15.3.5. By End User 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Product Type 16.2.3. By Insertion Technique 16.2.4. By Indication 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product Type 16.3.3. By Insertion Technique 16.3.4. By Indication 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Product Type 17.1.2.2. By Insertion Technique 17.1.2.3. By Indication 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Product Type 17.2.2.2. By Insertion Technique 17.2.2.3. By Indication 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Product Type 17.3.2.2. By Insertion Technique 17.3.2.3. By Indication 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Product Type 17.4.2.2. By Insertion Technique 17.4.2.3. By Indication 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Product Type 17.5.2.2. By Insertion Technique 17.5.2.3. By Indication 17.5.2.4. By End User 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Product Type 17.6.2.2. By Insertion Technique 17.6.2.3. By Indication 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Product Type 17.7.2.2. By Insertion Technique 17.7.2.3. By Indication 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Product Type 17.8.2.2. By Insertion Technique 17.8.2.3. By Indication 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Product Type 17.9.2.2. By Insertion Technique 17.9.2.3. By Indication 17.9.2.4. By End User 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Product Type 17.10.2.2. By Insertion Technique 17.10.2.3. By Indication 17.10.2.4. By End User 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Product Type 17.11.2.2. By Insertion Technique 17.11.2.3. By Indication 17.11.2.4. By End User 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Product Type 17.12.2.2. By Insertion Technique 17.12.2.3. By Indication 17.12.2.4. By End User 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Product Type 17.13.2.2. By Insertion Technique 17.13.2.3. By Indication 17.13.2.4. By End User 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Product Type 17.14.2.2. By Insertion Technique 17.14.2.3. By Indication 17.14.2.4. By End User 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Product Type 17.15.2.2. By Insertion Technique 17.15.2.3. By Indication 17.15.2.4. By End User 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Product Type 17.16.2.2. By Insertion Technique 17.16.2.3. By Indication 17.16.2.4. By End User 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Product Type 17.17.2.2. By Insertion Technique 17.17.2.3. By Indication 17.17.2.4. By End User 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Product Type 17.18.2.2. By Insertion Technique 17.18.2.3. By Indication 17.18.2.4. By End User 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Product Type 17.19.2.2. By Insertion Technique 17.19.2.3. By Indication 17.19.2.4. By End User 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Product Type 17.20.2.2. By Insertion Technique 17.20.2.3. By Indication 17.20.2.4. By End User 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Product Type 17.21.2.2. By Insertion Technique 17.21.2.3. By Indication 17.21.2.4. By End User 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2022 17.22.2.1. By Product Type 17.22.2.2. By Insertion Technique 17.22.2.3. By Indication 17.22.2.4. By End User 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2022 17.23.2.1. By Product Type 17.23.2.2. By Insertion Technique 17.23.2.3. By Indication 17.23.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product Type 18.3.3. By Insertion Technique 18.3.4. By Indication 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. B. Braun Melsungen AG 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. Teleflex Incorporated 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Halyard Health, Inc. 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. Ambu A/S 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. Epimed International 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. Pajunk GmbH 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. LAERDAL 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. MEDLINE 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. TELEFLEX MEDICAL 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. Others 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports